Inventor
RIEDL BERND
DE31 patents
⚠️ This page may combine multiple inventors who share the name “RIEDL BERND”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BAYER AG
14 patentsUS5792765AAug 11, 1998
Substituted oxazolidinones
BAYER AG103 citations97
US5529998AJun 25, 1996
Benzoxazolyl- and benzothiazolyloxazolidinones
BAYER AG122 citations97
US6069160AMay 30, 2000
Heteroatom-containing benzocyclopentane-oxazolidinones
BAYER AG77 citations96
US5922708AJul 13, 1999
Heteroaryl-oxazolidinones
BAYER AG66 citations96
US5843967ADec 1, 1998
6-membered nitrogen-containing heteroaryl-oxazolidinones
BAYER AG48 citations96
US5827857AOct 27, 1998
Pyrido-fused thienyl- and furanyl-oxazolidinones
BAYER AG78 citations96
US5698574ADec 16, 1997
5-membered heteroaryl-oxazolidinones
BAYER AG84 citations96
US5684023ANov 4, 1997
Benzofuranyl -and benzothienyloxazolidinones
BAYER AG68 citations96
US5627181AMay 6, 1997
6-membered nitrogen-containing heteroaryl-oxazolidinones
BAYER AG87 citations95
US5869659AFeb 9, 1999
Heteroatom-containing cyclopentanopyridyl-oxazolidinones
BAYER AG85 citations94
US5861413AJan 19, 1999
2-oxo- and 2-thio-1,2-dihydroquinolinyl-oxazolidinones
BAYER AG51 citations92
US6589949B1Jul 8, 2003
3-oxo-2,1-benzisoxazol-1(3H)-carboxamides for treatment of CNS diseases
BAYER AG23 citations91
US6900194B1May 31, 2005
Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
BAYER AG3 citations59
US6344471B1Feb 5, 2002
2-aminocarbonyl-5(2H)-isoxazolones as ligands of a DFP-binding site treatment of CNS-diseases
BAYER AG0 citations38
BAYER PHARMACEUTICALS CORP
4 patentsUS7235576B1Jun 26, 2007
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
BAYER PHARMACEUTICALS CORP94 citations97
US7351834B1Apr 1, 2008
ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
BAYER PHARMACEUTICALS CORP64 citations96
US7528255B2May 5, 2009
Hydroxy, ω-carboxyaryl substituted diphenyl ureas and dirivatives thereof as raf kinase inhibitors
BAYER PHARMACEUTICALS CORP35 citations91
US7371763B2May 13, 2008
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
BAYER PHARMACEUTICALS CORP17 citations83
BAYER HEALTHCARE LLC
3 patentsUS7678811B2Mar 16, 2010
Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors
BAYER HEALTHCARE LLC57 citations98
US7897623B2Mar 1, 2011
ω-carboxyl aryl substituted diphenyl ureas as p38 kinase inhibitors
BAYER HEALTHCARE LLC35 citations92
US7928239B2Apr 19, 2011
Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
BAYER HEALTHCARE LLC15 citations83